ArticleCell death & disease2026
BACH1 stabilization by antioxidants facilitates hepatocellular carcinoma metastasis.
Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lactate acts as a metabolic brake on inflammation by repressing NLRP3 transcription via NF-κB inhibition.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Reactive oxygen species (ROS) plays certain contradictory and complex roles in the carcinogenesis and progression of cancers. In such process, antioxidants enable to promote the malignant invasion and migration of hepatocellular carcinoma (HCC) cells, but the underlying mechanisms remain elusive. Here, we found that two antioxidants, glutathione (GSH) and N-acetylcysteine (NAC), stabilized BACH1 (i.e., BTB and CNC homology 1) by decreasing ROS levels, thus facilitated BACH1-dependent migration of HCC cells in vitro and their metastasis in vivo. Mechanistically, knockout of BACH1 mildly alleviated endoplasmic reticulum stress/adaptive unfolded protein response (UPR) and repressed epithelial-mesenchymal transition (EMT) to inhibit cell migration. Further examinations revealed that BACH1 binds to consensus ARE sites in the promoter regions of key genes responsible for glycolytic pathway to activate their transcription, while concurrently repressing the expression of mitochondrial respiratory chain genes. This dual regulation thereby promoted the Warburg effect and facilitated HCC cell migration driven by glycolysis. The BACH1-regulated metabolic reprogramming was further unraveled by non-targeted metabolomics. Collectively, these demonstrate that the redox-sensitive transcription factor BACH1 functions as a crucial metastasis-promoter of HCC, and thus antioxidants stimulate BACH1-dependent HCC metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.